OPTILATER: A Cross-Sectional Study Design for Evaluating Long-Term Survival and Care Conditions Among Cancer Survivors in Germany
By
C. N. Martin
N. De Lazzari
J. Kersten
K. Claassen
C. Jansen
K. Kaminski
F. Baumann
M. Götte
S. Palm
A. Stang
V. Grünwald
U. Dirksen
M. A. Teufel
E.-M. Skoda
October 24, 2025
Clinical Scorecard: OPTILATER: A Cross-Sectional Study Design for Evaluating Long-Term Survival and Care Conditions Among Cancer Survivors in Germany
At a Glance
Category Detail
Condition Long-term cancer survivorship Key Mechanisms Evaluation of late effects of cancer treatment and follow-up care needs Target Population Long-term cancer survivors in North Rhine-Westphalia, Germany Care Setting Multisite study across North Rhine-Westphalia
Key Highlights
4.65 million cancer survivors in Germany as of 2017 Focus on late effects of cancer treatment and follow-up care Diverse participant recruitment including individuals with migration backgrounds Assessment of health-related quality of life and unmet needs Integration of qualitative and quantitative research methodologies Guideline-Based Recommendations
Diagnosis
Confirm history of cancer diagnosis for participant eligibility Management
Evaluate late effects and follow-up care requirements for long-term survivors Monitoring & Follow-up
Utilize Patient-Reported Outcome Measures (PROMs) for health-related quality of life assessment Risks
Address potential disparities in care among ethnic minority populations Patient & Prescribing Data
Long-term cancer survivors free from active tumor recurrence for at least five years
Focus on assessing care needs rather than medical interventions
Clinical Best Practices
Employ structured quantitative surveys to assess survivor experiences Integrate qualitative insights to enrich understanding of survivor needs Align study framework with established long-term cancer care guidelines References
